Non-invasive determination of likely response to anti-diabetic therapies for cardiovascular disease
US11887713B2 · kind B2 · utility
13Cited by
16References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 2022 |
| Grant date | Jan 30, 2024 |
| Priority date | — |
| Expiry date | Jun 10, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H50/50
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.